Costs of orphan medicinal products: longitudinal analysis of expenditure in Wales

被引：0
|
作者：
Yankier Pijeira Perez
Eifiona Wood
Dyfrig A Hughes
机构：
[1] Bangor University,Centre for Health Economics and Medicines Evaluation
来源：
Orphanet Journal of Rare Diseases | / 18卷
关键词：
Orphan Drugs; Drug costs; Costs analysis, health economics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Global regulatory considerations for early stage development of orphan medicinal products
    Parsley, Kathryn
    Lecomte-Farrell, Veronica
    Hannus, Henrik
    Madichie, Elizabeth
    McCormick, James
    HUMAN GENE THERAPY, 2013, 24 (05) : A31 - A31
  • [32] DETERMINANTS OF THE OPTIMAL ROUTE TO REIMBURSEMENT FOR ORPHAN MEDICINAL PRODUCTS (OMPS) IN ENGLAND
    Sattar, S.
    Marshall, J. D.
    Hill, C. A.
    VALUE IN HEALTH, 2017, 20 (09) : A569 - A569
  • [33] Orphan medicinal products: assessment after 5 years of European legislation
    Borensztein, P
    M S-MEDECINE SCIENCES, 2006, 22 (01): : 71 - 74
  • [34] Off-label use of orphan medicinal products: a Belgian qualitative study
    Marc Dooms
    David Cassiman
    Steven Simoens
    Orphanet Journal of Rare Diseases, 11
  • [35] Development and validation of COMPASS: clinical evidence of orphan medicinal products – an assessment tool
    Eline Picavet
    David Cassiman
    Bert Aertgeerts
    Steven Simoens
    Orphanet Journal of Rare Diseases, 8
  • [36] Off-label use of orphan medicinal products: a Belgian qualitative study
    Dooms, Marc
    Cassiman, David
    Simoens, Steven
    ORPHANET JOURNAL OF RARE DISEASES, 2016, 11 : 1 - 9
  • [37] Trends in orphan medicinal products approvals in the European Union between 2010–2022
    Luísa Bouwman
    Bruno Sepodes
    Hubert Leufkens
    Carla Torre
    Orphanet Journal of Rare Diseases, 19
  • [38] European regulation on orphan medicinal products: 10 years of experience and future perspectives
    Nature Reviews Drug Discovery, 2011, 10 : 341 - 349
  • [39] European regulation on orphan medicinal products: 10 years of experience and future perspectives
    Westermark, Kerstin
    Holm, Birthe Byskov
    Soderholm, Mirjam
    Llinares-Garcia, Jordi
    Riviere, Frida
    Aarum, Stiina
    Butlen-Ducuing, Florence
    Tsigkos, Stelios
    Wilk-Kachlicka, Agnieszka
    N'Diamoi, Cinzia
    NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (05) : 341 - 349
  • [40] Development and validation of COMPASS: clinical evidence of orphan medicinal products - an assessment tool
    Picavet, Eline
    Cassiman, David
    Aertgeerts, Bert
    Simoens, Steven
    ORPHANET JOURNAL OF RARE DISEASES, 2013, 8
12345